Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children

Descripción del Articulo

Objective: To determine the utility of the triglycerides/HDL-C index for the diagnosis of metabolic syndrome (MS) in obese 2-14 years of age children. Methods: Cross-sectional diagnostic study. We included 360 exogenous obese children (199M/161F) divided in three age groups: 2 to <6;...

Descripción completa

Detalles Bibliográficos
Autores: Cabello, Emilio, Martínez, Melissa, Cabrera, Ysel, Villafuerte, Susan, González, Isolda
Formato: artículo
Fecha de Publicación:2020
Institución:Universidad Peruana Cayetano Heredia
Repositorio:Revistas - Universidad Peruana Cayetano Heredia
Lenguaje:español
OAI Identifier:oai:revistas.upch.edu.pe:article/3660
Enlace del recurso:https://revistas.upch.edu.pe/index.php/RMH/article/view/3660
Nivel de acceso:acceso abierto
Materia:Índice TG/HDL-C, síndrome metabólico, niños
TG / HDL-C ratio, metabolic syndrome, children
id REVUPCH_fbc79b8b928cb5ab385e495983d7a60c
oai_identifier_str oai:revistas.upch.edu.pe:article/3660
network_acronym_str REVUPCH
network_name_str Revistas - Universidad Peruana Cayetano Heredia
repository_id_str
spelling Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese childrenUtilidad del índice triglicéridos/HDL-C desde los primeros años de vida en el diagnóstico de síndrome metabólico en niños obesosCabello, EmilioMartínez, MelissaCabrera, YselVillafuerte, SusanGonzález, IsoldaÍndice TG/HDL-C, síndrome metabólico, niñosTG / HDL-C ratio, metabolic syndrome, childrenObjective: To determine the utility of the triglycerides/HDL-C index for the diagnosis of metabolic syndrome (MS) in obese 2-14 years of age children. Methods: Cross-sectional diagnostic study. We included 360 exogenous obese children (199M/161F) divided in three age groups: 2 to <6; 6 to <10 and 10-14 years. MS was defined according to the International Diabetes Federation and the TG/HDL-C index was evaluated using two cutoffs by age group, ≥2.32 and ≥3.5. Chi squared was used accepting a p value <0.05 as statistically significant. Fir each cut-off we determined sensitivity, specificity and predictive values. Results: Frequency of MS was 15.79% in the 2 to <6 years age group; 20.25% in the 6 to<10 years age group and 19.63% in the 10-14 years age group. Among children with SM, 97.1% had low HDL and 83.8% had elevated triglycerides. A statistically significant difference was found in the frequency of the TG/HDL-C index in children with or without MS in all age groups. Sensitivity for all cut-offs was high (86-100%) and specificity was best for the cut-off of ≥3.5 (72-80%). Conclusions: The TG/HDL-C index is a sensitive and specific marker of MS from the first years of age.Objetivo: Determinar la utilidad del índice triglicéridos/HDL-C (TG/HDL-C) para el diagnóstico de síndrome metabólico (SM) en niños obesos de 2 a 14 años. Material y métodos: Estudio transversal tipo prueba de diagnóstico. Fueron incluidos 360 niños obesos exógenos (199M/161F), divididos en tres grupos etarios: 2 a <6 años, 6 a <10 años y 10 a 14 años. Se definió SM según los criterios de la International Diabetes Federation y se evaluó al índice TG/HDL-C como diagnóstico en dos puntos de corte: ≥2,32 y ≥3,5, en cada grupo etario. Se aplicó Chi cuadrado, considerándose significativo p<0,05. Se determinó la sensibilidad, especificidad y valores predictivos positivo y negativo, para cada punto de corte. Resultados: La frecuencia de SM fue 15,79% de 2 a <6 años, 20,25% de 6 a <10 años, 19,63% de 10 a 14 años. En los niños con SM el 97,1% presentó HDL bajo, 83,8% triglicéridos elevados. Se encontró diferencia significativa en la frecuencia del índice TG/HDL-C en ambos puntos de corte, entre los niños con y sin SM en todos los grupos etarios. La sensibilidad para ambos puntos de corte fue alta (86-100%) y la especificidad fue mejor para el punto de corte ≥3,5 (72-80%). Conclusiones: El índice TG/HDL-C ≥3,5 representaría un marcador sensible y específico para el diagnóstico de síndrome metabólico desde los primeros años de vida.Universidad Peruana Cayetano Heredia2020-01-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed articleArtículo evaluado por paresapplication/pdfhttps://revistas.upch.edu.pe/index.php/RMH/article/view/366010.20453/rmh.v30i4.3660Revista Médica Herediana; Vol. 30 No. 4 (2019): October - December; 249-255Revista Médica Herediana; Vol. 30 Núm. 4 (2019): Octubre - Diciembre; 249-255Revista Medica Herediana; v. 30 n. 4 (2019): Outubro - dezembro; 249-2551729-214X1018-130Xreponame:Revistas - Universidad Peruana Cayetano Herediainstname:Universidad Peruana Cayetano Herediainstacron:UPCHspahttps://revistas.upch.edu.pe/index.php/RMH/article/view/3660/4060info:eu-repo/semantics/openAccessoai:revistas.upch.edu.pe:article/36602024-01-11T01:58:08Z
dc.title.none.fl_str_mv Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
Utilidad del índice triglicéridos/HDL-C desde los primeros años de vida en el diagnóstico de síndrome metabólico en niños obesos
title Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
spellingShingle Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
Cabello, Emilio
Índice TG/HDL-C, síndrome metabólico, niños
TG / HDL-C ratio, metabolic syndrome, children
title_short Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
title_full Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
title_fullStr Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
title_full_unstemmed Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
title_sort Utility of the triglycerides/HDL-C index from the first years of age in the diagnosis of metabolic syndrome in obese children
dc.creator.none.fl_str_mv Cabello, Emilio
Martínez, Melissa
Cabrera, Ysel
Villafuerte, Susan
González, Isolda
author Cabello, Emilio
author_facet Cabello, Emilio
Martínez, Melissa
Cabrera, Ysel
Villafuerte, Susan
González, Isolda
author_role author
author2 Martínez, Melissa
Cabrera, Ysel
Villafuerte, Susan
González, Isolda
author2_role author
author
author
author
dc.subject.none.fl_str_mv Índice TG/HDL-C, síndrome metabólico, niños
TG / HDL-C ratio, metabolic syndrome, children
topic Índice TG/HDL-C, síndrome metabólico, niños
TG / HDL-C ratio, metabolic syndrome, children
description Objective: To determine the utility of the triglycerides/HDL-C index for the diagnosis of metabolic syndrome (MS) in obese 2-14 years of age children. Methods: Cross-sectional diagnostic study. We included 360 exogenous obese children (199M/161F) divided in three age groups: 2 to <6; 6 to <10 and 10-14 years. MS was defined according to the International Diabetes Federation and the TG/HDL-C index was evaluated using two cutoffs by age group, ≥2.32 and ≥3.5. Chi squared was used accepting a p value <0.05 as statistically significant. Fir each cut-off we determined sensitivity, specificity and predictive values. Results: Frequency of MS was 15.79% in the 2 to <6 years age group; 20.25% in the 6 to<10 years age group and 19.63% in the 10-14 years age group. Among children with SM, 97.1% had low HDL and 83.8% had elevated triglycerides. A statistically significant difference was found in the frequency of the TG/HDL-C index in children with or without MS in all age groups. Sensitivity for all cut-offs was high (86-100%) and specificity was best for the cut-off of ≥3.5 (72-80%). Conclusions: The TG/HDL-C index is a sensitive and specific marker of MS from the first years of age.
publishDate 2020
dc.date.none.fl_str_mv 2020-01-13
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-reviewed article
Artículo evaluado por pares
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://revistas.upch.edu.pe/index.php/RMH/article/view/3660
10.20453/rmh.v30i4.3660
url https://revistas.upch.edu.pe/index.php/RMH/article/view/3660
identifier_str_mv 10.20453/rmh.v30i4.3660
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://revistas.upch.edu.pe/index.php/RMH/article/view/3660/4060
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidad Peruana Cayetano Heredia
publisher.none.fl_str_mv Universidad Peruana Cayetano Heredia
dc.source.none.fl_str_mv Revista Médica Herediana; Vol. 30 No. 4 (2019): October - December; 249-255
Revista Médica Herediana; Vol. 30 Núm. 4 (2019): Octubre - Diciembre; 249-255
Revista Medica Herediana; v. 30 n. 4 (2019): Outubro - dezembro; 249-255
1729-214X
1018-130X
reponame:Revistas - Universidad Peruana Cayetano Heredia
instname:Universidad Peruana Cayetano Heredia
instacron:UPCH
instname_str Universidad Peruana Cayetano Heredia
instacron_str UPCH
institution UPCH
reponame_str Revistas - Universidad Peruana Cayetano Heredia
collection Revistas - Universidad Peruana Cayetano Heredia
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1847421192335523840
score 12.63363
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).